medigraphic.com
ISSN 2992-8036 (Electronic)
ISSN 2306-4102 (Print)
Órgano Oficial del Colegio Mexicano de Ortopedia y Traumatología

2016, Number 1

<< Back

Acta Ortop Mex 2016; 30 (1)

Charcot arthropathy and diabetic foot

López-Gavito E, Parra-Téllez P, Vázquez-Escamilla J

Language: Spanish
References: 113
Page: 33-45
PDF size: 358.30 Kb.


ABSTRACT

Diabetes mellitus is a major chronic degenerative disease, which currently is taking on alarming proportions in the population of our country. Neuropathic arthropathy is one of the most interesting degenerative joint disorders and increasingly common within the orthopedic pathology. It is defined as a progressive degenerative arthropathy, chronic and affecting one or more peripheral joints, and develops as a result of the lack of sensory perception normal in the innervation of joints. As a result the joints of the feet are subjected to trauma and repetitive injury causing a neurotraumatic effect with progressive damage to the joints of the hindfoot, midfoot and forefoot. Diagnosis includes a proper medical history, careful examination of the affected limb, conventional X-ray, scintigraphy, computed tomography and magnetic resonance imaging in some cases. Conservative treatment includes: drugs, rest of the affected limb, and the use of appliances like total-contact cast, orthotics or special shoes. Surgical treatment depends on the stage of the disease, and may require one or more surgical procedures, in order to achieve a full foot plantar support to prevent ulcers. One of the surgeries performed most often is the fusion of damaged joints. Surgery must be performed only in the coalescence phase of the disease, using internal, or external fixation or both.


REFERENCES

  1. Armstrong DG, Frykberg RG. Classifying diabetic foot surgery: toward a rational definition. Diabet Med. 2003; 20: 329-31.

  2. Eloesser L: On the nature of neuropathic affections of the joints. Ann Surg. 1917; 66: 201-7.

  3. Molines L, Darmon P, Raccah D: Charcot’s foot: newest findings on its pathophysiology, diagnosis and treatment. Diabetes Metab. 2010; 36: 251-5.

  4. Charcot JM, Fere C: Affection’s osseuses et articulaires du pied chez les tabétiques (Pied tabétique). Archives de Neurologie. 1883; 6: 305-19 [in French].

  5. Charcot JM: Sur quelques arthropathies qui paraissent dépendre d’une lésion du cerveau ou de la moëlle épiničre. Arch Physiol Norm Pathol. 1868; 1: 161-78.

  6. Jordan WR. Neuritic manifestations in diabetes mellitus. Arch Intern Med. 1936; 57: 307-58.

  7. Chandler GN, Wright V: Deleterious effects of intra-articular hydrocortisone. Lancet. 1958; 2: 661-3.

  8. Cofield RH, Morrison MJ, Beabout JW: Diabetic neuroarthropathy in the foot: patient characteristics and patterns of radiographic change. Foot Ankle. 1983; 4: 15-22.

  9. Early J: Surgical intervention in diabetic neuroarthropathy of the foot. Foot Ankle Clin. 1997; 1: 23-36.

  10. Henderson VE: Joint affections in tabes dorsalis. J Pathol. 1905; 10: 211-64.

  11. Höpfner S, Krolak C, Kessler S, Tiling R: Preoperative imaging of Charcot neuroarthropathy. Does the additional application of (18)F-FDG-PET make sense? Nuklearmedizin. 2006; 45: 15-20.

  12. Harris JR, Brand PW: Patterns of disintegration of the tarsus in the anaesthetic foot. J Bone Joint Surg Br. 1966; 48: 4-16.

  13. Larcos G, Brown ML, Sutton RT: Diagnosis of osteomyelitis of the foot in diabetic patients: value of 111In-leukocyte scintigraphy. AJR Am J Roentgenol. 1991; 157: 527-31.

  14. Saltzman CL, Johnson KA, Goldstein RH, et al: The patellar tendon-bearing brace as treatment for neurotrophic arthropathy: A dynamic force monitoring study. Foot Ankle. 1992; 13: 14-21.

  15. Ulbrecht JS, Wukich DK: The Charcot foot: medical and surgical therapy. Curr Diab Rep. 2008; 8: 444–51.

  16. Foster B. Basset: Neurogenic arthropaty associated with diabetic neuropathy. Arch NeuroPsych. 1947; 57(2): 173-85.

  17. Shaw JE, Boulton AJM: The Charcot foot. Foot. 1995; 5: 65-70.

  18. Johnson JTH: Neuropathic fractures and joint injuries: Pathogenesis and rationale of prevention and treatment. J Bone Joint Surg Am. 1967; 49: 1-30.

  19. Baker N, Green A, Krishnan S, Rayman G: Microvascular and C-fiber function in diabetic Charcot neuroarthropathy and diabetic peripheral neuropathy. Diabetes Care. 2007; 30: 3077-9.

  20. Herbst SA, Jones KB, Saltzman CL: Pattern of diabetic neuropathic arthropathy associated with the peripheral bone mineral density. J Bone Joint Surg Br. 2004; 86: 378-83.

  21. Jeffcoate WJ, Game FL: New theories on the causes of the Charcot foot in diabetes. In: Frykberg RG, ed. The diabetic Charcot foot: principles and management. Ed. Brooklandville, MD: Data Trace Publishing Company; 2010: 29-44.

  22. Calabro JJ, Garg SL: Neuropathic joint disease. Am Fam Physician. 1973; 7: 90-5.

  23. Trepman E, Nihal A, Pinzur M: Charcot neuroarthropathy of the foot and ankle. Foot Ankle Int. 2005; 26: 46-63.

  24. Young MJ, Marshall A, Adams JE, Selby PL, Boulton AJ: Osteopenia, neurological dysfunction and the development of Charcot neuroarthropathy. Diabetes Care. 1995; 18: 34-8.

  25. Archer AG, RobertsPJ: Blood flow patterns in periferial diabetic neurophaty. Diabetologia. 1984; 27: 563.

  26. Boulton AJM, Kubrusly DB, Bowker JH, et al: Impaired vibratory perception and diabetic foot ulceration. Diabet Med. 1986; 3: 335-7.

  27. Finsterbush A, Friedman B: The effect of sensory denervation on rabbits’ knee joints. J Bone Joint Surg Am. 1975; 57(7): 949-56.

  28. O’Connor BL, Visco DM, Brandt KD, et al: Neurogenic acceleration of osteoarthrosis: The effects of previous neurectomy of the articular nerves on the development of osteoarthrosis after transection of the anterior cruciate ligament in dogs. J Bone Joint Surg Am. 1992; 74: 367-76.

  29. Trotman NM, Kelly WD: The effect of sympathectomy on blood flow to bone. JAMA. 1963; 183: 121.

  30. Boulton AJ, Scarpello JH, Ward JD: Venous oxygenation in the diabetic neuropathic foot: evidence of arteriovenous shunting? Diabetologia. 1982; 22: 6-8.

  31. Edmonds ME, Morrison N, Laws JW, et al: Medial arterial calcification and diabetic neuropathy. Br Med J. 1983; 284: 928-30.

  32. Clohisy DR, Thompson RC: Fractures associated with neuropathic arthropathy in adults who have juvenile-onset diabetes. J Bone Joint Surg Am . 1988; 70: 1192-200.

  33. Duncan CP, Shim SS: The autonomic nerve supply of bone. J Bone Joint Surg. 1977; 59B: 323.

  34. Veves A, Akbari CM, Primavera J, et al: Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes. 1998; 47: 457-63.

  35. Jeffcoate W: The causes of the Charcot syndrome. Clin Podiatr Med Surg. 2008; 25: 29-42.

  36. Jeffcoate WJ, Game F, Cavanagh PR: The role of pro inflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes. Lancet. 2005; 366: 2058-61.

  37. Newman JH: Non-infective disease of the diabetic foot. J Bone Joint Surg Br. 1981; 63: 593-6.

  38. Sanders LJ, Frykberg RG: The Charcot foot (Pied de Charcot). In: Bowker JH, Pfeifer MA, eds. Levin and O’Neal’s the diabetic foot. 7th ed. Eds. Philadelphia: Mosby Elsevier; 2007: 257-83.

  39. Sinha S, Munichoodappa C, Kozak GP: Neuroarthropathy (Charcot’s joints) in diabetes mellitus: a clinical study of 101 cases. Medicine (Baltimore). 1972; 51: 191-210.

  40. Uccioli L, Sinistro A, Almerighi C, et al: Pro inflammatory modulation of the surface and cytokine phenotype of monocytes in patients with acute Charcot foot. Diabetes Care. 2010; 33: 350-5.

  41. Fabrin J, Larsen K, Holstein PE. Long-term follow-up in diabetic Charcot feet with spontaneous onset. Diabetes Care. 2000; 23: 796-800.

  42. Morrison WB, Shortt CP, Ting AYI: Imaging of the Charcot foot. In: Frykberg RG, ed. The diabetic Charcot foot: principles and management. Brooklandville, MD: Data Trace Publishing Company; 2010: 65-84.

  43. Pinzur M: Surgical vs accommodative treatment for Charcot Arthropathy of the midfoot. Foot Ankle Int. 2004, 25: 545-9.

  44. Stevens MJ, Edmonds ME, Foster AV, Watkins PJ: Selective neuropathy and preserved vascular responses in the diabetic Charcot foot. Diabetologia. 1992; 35: 148-54.

  45. Wukich DK, Sung W: Charcot arthropathy of the foot and ankle: modern concepts and management review. J Diabetes Complications. 2009; 23: 409-26.

  46. Uccioli L, Caselli A, Giacomozzi C, Macellari V, Giurato L, Lardieri L, et al: Pattern of abnormal tangential forces in the diabetic neuropathic foot. Clin Biom. 2001; 16: 446-54.

  47. Shapiro SA, Stansberry KB, Hill MA, et al. Normal blood flow response and vasomotion in the diabetic Charcot foot. J Diabetes Complications. 1998; 12: 147-53.

  48. Caputo GM, Ulbrecht J, Cavanagh PR, Juliano P: The Charcot foot in diabetes: six key points. Am Fam Physician. 1998; 57: 2705-10.

  49. Foltz KD, Fallat LM, Schwartz S. Usefulness of a brief assessment battery for early detection of Charcot foot deformity in patients with diabetes. J Foot Ankle Surg. 2004; 43: 87-92.

  50. Gardner SE, Frantz RA, Doebbeling BN: The validity of the clinical signs and symptoms used to identify localized chronic wound infection. Wound Repair Regen. 2001; 9: 178-86.

  51. Clouse ME, Gramm HF, Legg M, Flood T: Diabetic osteoarthropathy. Clinical and roentgenographic observations in 90 cases. Am J Roentgenol Radium Ther Nucl Med. 1974; 121: 22-34.

  52. Coebel FD, Fuessel HS: Mönckeberg’s sclerosis after sympathetic denervation in diabetic and non diabetic subjects. Diabetologia. 1983; 24(5): 347-50.

  53. Das PC, Banerji A, Roy A, et al: Neurogenic arthropathies (Charcot’s joint). J Indian Med Assoc. 1970; 54: 368-72.

  54. Eichenholtz SN: Charcot Joints. Springfield, IL: Charles C. Thomas; 1966.

  55. Edmonds ME, Roberts VC, Watkins PJ: Blood flow in the diabetic neuropathic foot. Diabetologia. 1982; 22: 9-15.

  56. Matricali GA, Bammens B, Kuypers D, Flour M, Mathieu C: High rate of Charcot foot attacks early after simultaneous pancreas-kidney transplantation. Transplantation. 2007; 83: 245-6.

  57. Boyce BF, Xing L: Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys. 2008; 473: 139-46.

  58. Pinzur M: Benchmark analysis of diabetic patients with neuropatic (Charcot) foot. Foot Ankle Int. 1999, 20: 564-71.

  59. Pinzur M, Stuck R, Sage R, et al: Analysis on diabetics at high risk for lower extremity amputation. Foot Ankle Int. 1996, 17: 695-700.

  60. Pinzur M, Sage R, Stuck R: A treatment algorithm for neuropatic (Charcot) midfoot deformity. Foot Ankle Int. 1993, 14: 189-97.

  61. Sammarco VJ, Sammarco GJ, Walker EW Jr, et al: Midtarsal arthrodesis in the treatment of Charcot midfoot arthropathy. J Bone Joint Surg Am. 2009; 91: 80-91.

  62. Brodsky JW, Rouse AM: Exostectomy for symptomatic bony prominences in diabetic Charcot feet. Clin Orthop Relat Res. 1993; 296: 21-6.

  63. Brodsky JW: Charcot joints. En: Mann RA, Coughlin MJ, eds. Surgery of the foot and ankle. St. Louis: Mosby; 1993: 925-53.

  64. Sammarco GJ, Conti SF: Surgical treatment of neuroarthropathic foot deformity. Foot Ankle Int. 1998; 19: 102-9.

  65. Schon LC, Easley ME, Weinfeld SB: Charcot neuroarthropathy of the foot and ankle. Clin Orthop. 1998; 116-31.

  66. Schon LC, Easley ME, Cohen I, et al: The acquired midtarsus deformity classification system interobserver reliability and intraobserver reproducibility. Foot Ankle Int. 2002; 23: 30-6.

  67. Strauss E, Gonya G: Adjunct low intensity ultrasound in Charcot neuroarthropathy. Clin Orthop Relat Res. 1998; (349): 132-8.

  68. Brower AC, Allman RM: Pathogenesis of the neurotrophic joint: Neurotraumatic vs. neurovascular. Radiology. 1981; 139: 349-54.

  69. Norman A, Robbins H, Milgram JE: The acute neuropathic arthropathy: A rapid, severely disorganizing form of arthritis. Radiology. 1968; 90: 1159-64.

  70. Morrison WB, Ledermann HP: Work-up of the diabetic foot. Radiol Clin North Am. 2002; 40: 1171-92.

  71. Morrison WB, Ledermann HP, Schweitzer ME: MR imaging of the diabetic foot. Magn Reson Imaging Clin N Am. 2001; 9: 603-13, xi.

  72. Mueller MJ, Maluf K, Sinacore DR, Hastings M, Strube MJ, Engsberg J, et al: Effect of tendo Achilles lengthening on forefoot plantar pressures, ankle motion and plantar flexor power during walking in subjects with diabetes and peripheral neuropathy: a prospective controlled clinical trial. Procs VIII EMED Scientific Meeting-Kananaskis, Alberta, Canada, July 31st–August 3rd, 2002: 25.

  73. Mabilleau G, Petrova NL, Edmonds ME, Sabokbar A: Increased osteoclastic activity in acute Charcot’s osteoarthropathy: the role of receptor activator of nuclear factor kappaB ligand. Diabetologia. 2008; 51:1035-40.

  74. Oyen WJ, Netten PM, Lemmens JA, et al: Evaluation of infectious diabetic foot complications with indium-111-labeled human nonspecific immunoglobulin G. J Nucl Med. 1992; 33: 1330-6.

  75. Edmonds ME, Clarke MB, Newton JB, et al: Increased uptake of bone radiopharmaceutical in diabetic neuropathy. Quarterly J Med. 1985; 57: 843.

  76. Eymontt MJ, Alavi A, Dalinka MK, et al: Bone scintigraphy in diabetic osteoarthropathy. Radiology. 1981; 140: 475.

  77. Heatherington VJ: Technitium and combined gallium and technitium scans in the neurotrophic foot. JAPA. 1982; 72: 458.

  78. Palestro CJ, Mehta HH, Patel M, et al: Marrow versus infection in the Charcot joint: indium-111 leukocyte and technetium- 99m sulfur colloid scintigraphy. J Nucl Med. 1998; 39: 346-50.

  79. Klenerman L: The Charcot neuroarthropathy joint in diabetes mellitus. Diabet Med. 1996; 13: S52-4.

  80. Selby PL, Young MJ, Boulton AJ. Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy? Diabet Med. 1994; 11: 28-31.

  81. Jude EB, Selby PL, Burgess J, et al: Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomized controlled trial. Diabetologia. 2001; 44: 2032-7.

  82. Pitocco D, Zelano G, Gioffrč G, et al: Association between osteoprotegerinG1181C and T245G polymorphisms and diabetic Charcot neuroarthropathy: a case control study. Diabetes Care. 2009; 32: 1694-7.

  83. Anderson JJ, Woelffer KE, Holtzman JJ, Jacobs AM: Bisphosphonates for the treatment of Charcot neuroarthropathy. J Foot Ankle Surg. 2004; 43: 285-9.

  84. Hofbauer LC, Hamann C, Ebeling PR: Approach to the patient with secondary osteoporosis. Eur J Endocrinol. 2010; 162: 1009-20.

  85. Hofbauer LC, Brueck CC, Singh SK, Dobnig H: Osteoporosis in patients with diabetes mellitus. J Bone Miner Res. 2007; 22: 1317-28.

  86. Bem R, Jirkovská A, Fejfarová V, Skibová J, Jude EB: Intranasal calcitonin in the treatment of acute Charcot neuro osteoarthropathy: a randomized controlled trial. Diabetes Care. 2006; 29: 1392-4.

  87. Pitocco D, Ruotolo V, Caputo S, et al: Six month treatment with alendronate in acute Charcot neuroarthropathy: a randomized controlled trial. Diabetes Care. 2005; 28: 1214-5.

  88. Schon LC, Marks RM: The management of neuroarthropathic fracture-dislocations in the diabetic patient. Orthop Clin North Am. 1995; 26: 375-92.

  89. Harrelson JM: Management of the diabetic foot. Orthop Clin North Am. 1989; 20: 605-19.

  90. Frykberg RG, Eneroth M: Principles of conservative management. In: Frykberg RG, ed. The diabetic charcot foot: principles and management. Brooklandville, MD: Data Trace Publishing Company; 2010: 93-116.

  91. Pinzur M, Lio T. Posner M: Treatment of Eichenholtz stage i charcot foot arthropathy with a weight-bearing total contact cast. Foot Ankle Int. 2006; 27: 324-9.

  92. Armstrong DG, Lavery LA, Wu S, Boulton AJ: Evaluation of removable and irremovable cast walkers in the healing of diabetic foot wounds: a randomized controlled trial. Diabetes Care. 2005; 28: 551-4.

  93. Banks AS, McGlamry ED: Charcot foot. J Am Pod Med Assoc. 1989; 79: 213-35.

  94. Armstrong DG, Short B, Espensen EH, Abu-Rumman PL, Nixon BP, Boulton AJ: Technique for fabrication of an “instant total-contact cast” for treatment of neuropathic diabetic foot ulcers. J Am Podiatr Med Assoc. 2002; 92: 405-8.

  95. Armstrong DG, Todd WF, Lavery LA, Harkless LB, Bushman TR: The natural history of acute Charcot’s arthropathy in a diabetic foot specialty clinic. Diabet Med. 1997; 14: 357-63.

  96. Armstrong DG, Lavery LA. Monitoring healing of acute Charcot’s arthropathy with infrared dermal thermometry. J Rehabil Res Dev. 1997; 34: 317-21.

  97. McGill M, Molyneaux L, Bolton T, Ioannou K, Uren R, Yue DK: Response of Charcot’s arthropathy to contact casting:assessment by quantitative techniques. Diabetologia. 2000; 43: 481-4.

  98. Frykberg R, Giurini J, Habershaw G, Rosenblum B, Chrzan J: Prophylactic surgery in the diabetic foot. In: Kominsky SJ, ed. Medical and surgical management of the diabetic foot. St. Louis: Mosby; 1993: 399-439.

  99. Mitchell JK: On a new practice in acute and chronic rheumatism. Am J Med Sci. 1831; 8: 55-64.

  100. Hockenbury RT, Gruttadauria M, McKinney I: Use of implantable bone growth stimulation in Charcot ankle arthrodesis. Foot Ankle Int. 2007; 28: 971-6.

  101. Petrisor B, Lau JT: Electrical bone stimulation: an overview and its use in high risk and Charcot foot and ankle reconstructions. Foot Ankle Clin. 2005; 10: 609-20, vii-viii.

  102. Basset AC: The development and application of pulsed electromagnetic fields (PEMFs) for united fractures and arthrodesis. Orthop Clin North Am. 1984; 15: 61-87.

  103. Stuart MJ, Morrey BF: Arthrodesis of the diabetic neuropathic ankle joint. Clin Orthop. 1990; 253: 209-11.

  104. Nwomeh BC, Yager DR, Cohen IK: Physiology of the chronic wound. Clin Plast Surg. 1998; 25: 341-56.

  105. Johnson J: Surgical Reconstruction of the diabetic foot and ankle. Foot Ankle Clin. 1997; 1: 37-56.

  106. Bono JV, Roger DJ, Jacobs RL: Surgical arthrodesis of the neuropathic foot: A salvage procedure. Clin Orthop. 1993; 296: 14-20.

  107. Sammarco VJ: Superconstructs in the treatment of Charcot foot deformity: plantar plating, lockedplating, and axial screw fixation. Foot Ankle Clin N Am. 2009; 14: 393-407.

  108. Myerson M. Henderson M. Saxby T: Management of midfoot diabetic neuroarthropathy. Foot Ankle Int. 1994; 15: 233-41.

  109. Robinson A, Pasapula C, Brodsky J: Surgical aspects of the diabetic foot. J Bone Joint Surg. 2009; 91 (B): 1-7

  110. Krause J, Brodsky JW: The natural history of type 1 midfoot neuropathic feet. Foot Ankle Clin. 1997: 2(1): 1-22.

  111. Carlson RE, Fleming LL, Hutton WC: The biomechanical relationship between the tendoachilles, plantar fascia and metatarsophalangeal joint dorsiflexion angle. Foot Ankle Int. 2000; 21: 18-25.

  112. Sanders LJ, Frykberg RG: Diabetic neuropathic osteoarthropathy: the Charcot foot. In: Fryberg RG, editor. The high risk foot in diabetes mellitus. New York: Churchill Livingstone; 1991: 297-338.

  113. Papa J, Myerson M, Girard P: Salvage, with arthrodesis, in intractable diabetic neuropathic arthropathy of the foot and ankle. J Bone Joint Surg Am. 1993; 75: 1056-66.




2020     |     www.medigraphic.com